ADCM 0110/26 - MISCELLANEOUS MEDICINES

This tender, designated as ADCM 0110/26, pertains to the acquisition of miscellaneous medicines. Similar to tender Q1/2737/2025, this procurement exercise aims to source a variety of pharmaceutical products. The designation 'ADCM' likely refers to the specific contracting entity or a particular framework agreement under which this procurement is being conducted. The scope involves obtaining a diverse assortment of medicines, the specifics of which will be detailed in the official tender documentation. This initiative is vital for ensuring the consistent availability of essential medications for the intended beneficiaries, which could include public health facilities, hospitals, or other healthcare providers. Bidders are expected to be reputable pharmaceutical manufacturers or licensed suppliers who can guarantee the quality, safety, and timely delivery of the specified drugs. Key evaluation factors will include the comprehensiveness of the supply offer, compliance with stringent pharmaceutical regulations, logistical capabilities, and overall cost-effectiveness. The objective is to establish a dependable source for a broad spectrum of medicinal supplies.

This is a supplies contract in the health and medical services, Monitoring Evaluation and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 25.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.